Please login to the form below

Not currently logged in

Diane DiGangi Trench appointed as country head of Sandoz UK

Previously, DiGangi Trench held the position of vice-president, market access and patient services at Sandoz in the US

Sandoz, the generics division of Novartis, has announced the appointment of Diane DiGangi Trench as its new UK country head.

Prior to becoming UK country head, DiGangi Trench (pictured right) held the position of vice-president, market access and patient services at Sandoz in the US.

In her new role, she will work to continue to expand access to biosimilar, generic and originator drugs for patients in the UK.

DiGangi Trench will be based in Sandoz’s headquarters in Camberley, and she will report to Christophe Delenta, the head of cluster I, Sandoz Region Europe.

“I am delighted to join the UK organisation as Country Head as we celebrate our 15 years in biosimilar medicines,” commented DiGangi Trench.

“Sandoz is a purpose-driven organisation and we are proud to support the NHS with our generic, biosimilar and originator medicines,” she added.

The appointment of DiGangi Trench also coincides with the 15th anniversary of the launch of Sandoz’s first biosimilar medicine approved for use in the UK, the company said in a statement.

12th May 2021

From: PME


COVID-19 Updates and Daily News

Featured jobs


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...